Moleculin Biotech, Inc.
Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment …
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
Moleculin Biotech, Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
Moleculin Biotech, Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of Moleculin Biotech, Inc..